Drug Free Solution, Inc.
DSOL
$0.0002
$0.000.00%
| 02/28/2014 | 11/30/2013 | 08/31/2013 | 05/31/2013 | 02/28/2013 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | 866.67% | 65.24% | 103.57% | -- |
| Gross Profit | -- | -166.67% | -65.24% | -99.07% | -- |
| SG&A Expenses | 4.88% | 171.47% | -94.82% | 2,863.45% | -72.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.88% | 255.74% | -80.20% | 721.84% | -72.63% |
| Operating Income | -4.88% | -249.86% | 80.20% | -700.00% | 72.61% |
| Income Before Tax | -4.88% | -249.86% | 80.20% | -284.93% | 72.61% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.88% | -249.86% | 80.20% | -284.93% | 72.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.88% | -249.86% | 80.20% | -284.93% | 72.61% |
| EBIT | -4.88% | -249.86% | 80.20% | -700.00% | 72.61% |
| EBITDA | -2.55% | -247.61% | 80.30% | -700.70% | -- |
| EPS Basic | 15.38% | -100.00% | 87.23% | -155.56% | 83.12% |
| Normalized Basic EPS | 12.50% | -100.00% | 86.21% | -437.50% | 83.33% |
| EPS Diluted | 15.38% | -100.00% | 87.23% | -155.56% | 83.12% |
| Normalized Diluted EPS | 12.50% | -100.00% | 86.21% | -437.50% | 83.33% |
| Average Basic Shares Outstanding | 23.21% | 63.96% | 58.87% | 54.10% | 57.44% |
| Average Diluted Shares Outstanding | 23.21% | 63.96% | 58.87% | 54.10% | 57.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
